Chinese herbal medicine combined with nucleotide analogues for compensated HBV-related cirrhosis: a systematic review of randomized controlled trials

Objective: To systematically evaluate the effectiveness and safety of Chinese herbal medicine (CHM) plus nucleotide analogues (NAs) for treating compensated HBV-related cirrhosis, the early stage of cirrhosis. Methods: PubMed, Cochrane library, China Network Knowledge Infrastructure Database (CNKI),...

Full description

Bibliographic Details
Main Authors: Tingting Li, Tianfang Wang, Yutong Fei, Xiaolin Xue, Xiuyan Wu
Format: Article
Language:English
Published: Elsevier 2015-01-01
Series:Journal of Traditional Chinese Medical Sciences
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2095754815000320